A haplotype of the methylenetetrahydrofolate reductase gene is protective against late-onset Alzheimer’s disease
Authors:
- Hisanori KowaHKHisanori Kowa
- Kenji NakashimaKNKenji Nakashima
- 1 March 2004
- journal article
- Published by Elsevier in Neurobiology of Aging
- Vol. 25 (3) , 291-294
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
- Ministry of Health, Labour and Welfare
This publication has 24 references indexed in Scilit:
- Full genome screen for Alzheimer disease: Stage II analysis*American Journal of Medical Genetics, 2002
- The Frequent 5,10-Methylenetetrahydrofolate Reductase C677T Polymorphism Is Associated with a Common Haplotype in Whites, Japanese, and AfricansThe American Journal of Human Genetics, 2002
- Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's DiseaseNew England Journal of Medicine, 2002
- Effects of common polymorphisms on the properties of recombinant human methylenetetrahydrofolate reductaseProceedings of the National Academy of Sciences, 2001
- Lack of replication of association findings in complex disease: an analysis of 15 polymorphisms in prior candidate genes for sporadic Alzheimer's diseaseEuropean Journal of Human Genetics, 2001
- The 1298A→C polymorphism in methylenetetrahydrofolate reductase (MTHFR): in vitro expression and association with homocysteineAtherosclerosis, 2001
- Gene structure of human and mouse methylenetetrahydrofolate reductase (MTHFR)Mammalian Genome, 1998
- Complete Genomic Screen in Late-Onset Familial Alzheimer DiseaseJAMA, 1997
- Apolipoprotein E allele–specific antioxidant activity and effects on cytotoxicity by oxidative insults and β–amyloid peptidesNature Genetics, 1996
- Thermolabile defect of methylenetetrahydrofolate reductase in coronary artery disease.Circulation, 1993